Menu
ETIOLOGY
Pathigenetic mechanism of Sars-CoV-2ETIOLOGY
SARS-COV-2 STRUCTURAL FEATURES
 |
Aerodynamic Characteristics and RNA Concentration of SARS-CoV-2 Aerosol in Wuhan Hospitals during COVID-19 Outbreak |
|---|
|
Analysis of Whole Genome Sequences and Homology Modelling of a 3-C Like Peptidase and a Non-Structural Protein of the... |
|---|
|
Co-infections of SARS-CoV-2 with multiple common respiratory pathogens in infected patients |
|---|
|
Coronavirus Disease 2019 (COVID-19): What we know? |
|---|
|
COVID‐2019: The role of the nsp2 and nsp3 in its pathogenesis |
|---|
|
Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2 |
|---|
|
Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites |
|---|
|
Discovery of a 382-nt deletion during the early evolution of SARS-CoV-2 |
|---|
|
Genetic evolution analysis of 2019 novel coronavirus and coronavirus from other species |
|---|
|
Genetic diversity and evolution of SARS-CoV-2 |
|---|
|
Genetic diversity and evolution of SARS-CoV-2 |
|---|
|
In silico study of the spike protein from SARS-CoV-2 interaction with ACE2: similarity with SARS-CoV... |
|---|
|
Novel coronavirus: From discovery to clinical diagnostics |
|---|
|
Nsp3 of coronaviruses: Structures and functions of a large multi-domain protein |
|---|
|
On the origin and continuing evolution of SARS-CoV-2 |
|---|
|
SARS-CoV-2 invades host cells via a novel route: CD147-spike protein |
|---|
|
SARS-CoV-2 receptor ACE2 and TMPRSS2 are predominantly expressed in a transient secretory cell type in subsegmental... |
|---|
|
Severe Acute Respiratory Syndrome Coronavirus as an Agent of Emerging and Reemerging Infection |
|---|
|
Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human... |
|---|
|
Spike protein binding prediction with neutralizing antibodies of SARS-CoV-2 |
|---|
|
Structure of Mpro from COVID-19 virus and discovery of its inhibitors |
|---|
|
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein |
|---|
|
The 2019 coronavirus (SARS-CoV-2) surface protein (Spike) S1 Receptor Binding Domain undergoes ... |
|---|
|
The insert sequence in SARS-CoV-2 enhances spike protein cleavage |
|---|
|
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak |
|---|
|
Understanding of COVID-19 based on current evidence |
|---|
|
Variant analysis of COVID-19 genomes |
|---|
SARS-COV-2 INFECTION
|
Aerodynamic Characteristics and RNA Concentration of SARS-CoV-2 Aerosol in Wuhan Hospitals during COVID-19 Outbreak |
|---|
|
A Familial Cluster of Infection Associated With the 2019 Novel Coronavirus Indicating Possible... |
|---|
|
Analysis of Whole Genome Sequences and Homology Modelling of a 3-C Like Peptidase and a Non-Structural Protein of the... |
|---|
|
Can the Coronavirus Disease 2019 (COVID-19) Affect the Eyes? A Review of Coronaviruses and Ocular... |
|---|
|
Co-infections of SARS-CoV-2 with multiple common respiratory pathogens in infected patients |
|---|
|
Coronavirus Disease 2019 (COVID-19): What we know? |
|---|
|
COVID‐2019: The role of the nsp2 and nsp3 in its pathogenesis |
|---|
|
Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2 |
|---|
|
Detection of SARS-CoV-2 in Different Types of Clinical Specimens |
|---|
|
Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein |
|---|
|
Genetic diversity and evolution of SARS-CoV-2 |
|---|
|
High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa |
|---|
|
Identification of a Potential Mechanism of Acute Kidney Injury During the Covid-19 Outbreak: A Study Based... |
|---|
|
Molecular immune pathogenesis and diagnosis of COVID-19 |
|---|
|
Novel coronavirus: From discovery to clinical diagnostics |
|---|
|
Nsp3 of coronaviruses: Structures and functions of a large multi-domain protein |
|---|
|
OSF Preprints | The ACE2 Expression in Sertoli cells and Germ cells may cause male reproductive disorder after SARS-CoV-2... |
|---|
|
Prediction modeling with data fusion and prevention strategy analysis for the COVID-19 outbreak |
|---|
|
Pulmonary pathology of early phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer |
|---|
|
Reduction and Functional Exhaustion of T Cells in Patients with Coronavirus Disease 2019 (COVID-19) |
|---|
|
Review and Prospect of Pathological Features of Corona Virus Disease |
|---|
|
SARS-CoV-2 invades host cells via a novel route: CD147-spike protein |
|---|
|
SARS-CoV-2 receptor ACE2 and TMPRSS2 are predominantly expressed in a transient secretory cell type in subsegmental... |
|---|
|
Severe Acute Respiratory Syndrome Coronavirus as an Agent of Emerging and Reemerging Infection |
|---|
|
Single Cell RNA Sequencing Analysis of Human Kidney Reveals the Presence of ACE2 Receptor: A Potential Pathway of... |
|---|
|
Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human... |
|---|
|
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein |
|---|
|
The difference in the incubation period of 2019 novel coronavirus (SARS-CoV-2) infection between travelers to... |
|---|
|
The insert sequence in SARS-CoV-2 enhances spike protein cleavage |
|---|
|
The neuroinvasive potential of SARS-CoV2 may be at least partially responsible for the respiratory failure of... |
|---|
|
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status |
|---|
|
The SARS-CoV-2 exerts a distinctive strategy for interacting with the ACE2 human receptor |
|---|
|
The within-host viral kinetics of SARS-CoV-2 |
|---|
|
Understanding of COVID-19 based on current evidence |
|---|
VIRUS STABILITY
|
A Familial Cluster of Infection Associated With the 2019 Novel Coronavirus Indicating Possible Person... |
|---|
|
Aerodynamic Characteristics and RNA Concentration of SARS-CoV-2 Aerosol in Wuhan Hospitals during COVID-19 Outbreak |
|---|
|
Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 |
|---|
|
Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1 |
|---|
|
Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents |
|---|
|
The difference in the incubation period of 2019 novel coronavirus (SARS-CoV-2) infection between ... |
|---|